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 Transporters must be sustained in proper working function at the plasma 
membrane to prevent serious harm to a cell.  A dysfunctional transporter may 
cause leaking of ions, loss of membrane potential, disturbed cell signaling, and 
even cell death.  Therefore, cautious monitoring of transporters occurs at the 
plasma membrane.  A transporter which becomes unfolded or unstable is quickly 
endocytosed and taken to the early endosome compartment of the cell.  
However, these unfolded transporters are not automatically degraded, as a cell 
attempts to preserve them by allowing time for refolding.  It is this process we 
refer to as quality control: where the decision is made whether to degrade the 
dysfunctional protein to maintain cell integrity or attempt to refold it to conserve 
energy.   The endosome provides a safe place where this decision can be made.  
Properly folded and functional transporters will return to the plasma membrane to 
resume pumping, while those deemed dysfunctional will continue on to be 
degraded.  
In the case of the yeast uracil transporter Fur4, unfolded/destabilized Fur4 
is ubiquitinated (signal for degradation added) by Rsp5, the only ubiquitin ligase 
known to work at the plasma membrane in yeast.  After being endocytosed and 
brought to the early endosome, the decision to degrade or recycle Fur4 is made 




It is known that ubiquitination status plays a major role in that decision, and that 
both ubiquitination and deubiquitination can occur at the early endosome.  
However, studies have shown that Fur4 can recycle in spite of being in a ubiquitin 
tagged state in some mutant strains, suggesting the quality control decision is not 
so black and white.   
 We attempt to elucidate this quality control process.  Our results, and 
those published, have led us to a model whereby ubiquitination status is not the 
sole deciding factor involved in sorting at the early endosome, but where 
retention of ubiquitinated cargo is actually the key sorting step.  Herein we 
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1.1 Protein Homeostasis 
Protein homeostasis, or proteostasis, is the maintenance of well 
functioning proteins in a cell required for its success and survival.  Unfolded 
proteins are a detriment to the cell because of loss of function, formation of 
protein aggregates, and triggering of cellular stress responses.  Unfolded 
proteins at the plasma membrane are especially detrimental to a cell, as they can 
cause leaking of ions and loss of membrane potential across the plasma 
membrane (PM).  Therefore, a cell must remove unfolded proteins from the 
plasma membrane immediately through what is called endocytosis, and eliminate 
the dysfunctional proteins through degradation.  The downside to this overly 
cautious system is that it can be energetically costly.  Degraded proteins have to 
be replaced through new protein synthesis (which requires a lot of energy) to 
maintain functioning proteins at the plasma membrane.  To conserve energy, 
proteins that are endocytosed are not always degraded.  These proteins are 
given time to refold, safely inside the cell, and then can be recycled back to the 
plasma membrane.  This process allows for the balance of cell integrity with 




plasma membrane, reevaluate/refold them, and then recycle and reuse the 
functional proteins while degrading the dysfunctional (1).  This system, whereby 
unfolded proteins are taken care of by being either refolded or degraded, is 
referred to as protein quality control (QC). 
There are different, but similar, protein quality control systems in place at 
other compartments in the cell as well as the plasma membrane.  The system in 
place at the Endoplasmic Reticulum (ER) acts as new proteins are synthesized 
and folded, before they are transported to their destination in the cell.  Generally, 
unfolded/misfolded proteins at the ER are held back and reevaluated by 
chaperone proteins, which assist in refolding, or when unsuccessful, aid in the 
protein being sent for degradation (2, 3).  The idea is similar to that at the plasma 
membrane, but the proteins involved in quality control, and the processes by 
which they work, are very different at each location.  For one thing, chaperones 
may not have as much access to membrane proteins at the endosome, so other 
QC mechanisms may be in place.  While ER quality control still lends itself to 
many unanswered questions, also obscure is the quality control system that 
works after a protein has reached the plasma membrane.   
The importance of having a protein quality control system in place is 
evident in diseases that result from loss of proteostasis.  Alzheimer’s disease, 
Parkinson’s disease, cystic fibrosis, prion diseases, and many more, all involve 
protein un-/mis-folding or protein aggregation (4–6).  Whether the observed 
imbalance in proteostasis is a causative factor or symptomatic attribute of the 
disease is often unknown.  Cystic fibrosis, however, is a clear example of the 




mammalian cystic fibrosis transmembrane conductance regulator (CFTR) protein 
unable to fold properly, is present in the vast majority of cystic fibrosis patients 
(7).  Even native CFTR, a large and cumbersome protein, simply takes too long 
to fold efficiently, and so it is often subjected to ER quality control and never 
makes it out of the ER.  Accordingly, about 75% of CFTRΔF508 protein is unable to 
fold and is held back in the endoplasmic reticulum (8).  Hence, not enough of the 
protein is able to make it to the plasma membrane where it serves as a chloride 
channel, and the repercussion is an imbalance of chloride ions, leading to many 
problems.  
The native CFTR protein that escapes the ER and makes it to the plasma 
membrane is still very unstable and frequently endocytosed (9).  CFTR has large 
cytosolic domains, and less region within the membrane, so it is able to be 
accessed by chaperones post-Golgi.  About 75% of the CFTR endocytosed is, in 
turn, recycled back to the plasma membrane (10).  So, the route of recycling 
instead of being degraded is very common for some proteins, and may be the 
norm.  It is also a vital pathway, as the degradation of all endocytosed native 
CFTR would also likely result in a cystic fibrosis phenotype, one would predict. 
Clearly, there is a very important quality control process going on directly after 
endocytosis, about which we know very little, and it will be discussed herein. 
 
1.2 Trafficking of Plasma Membrane Proteins 
 Proteins have predefined destinations in a cell, and specific routes to 
travel in getting there.  Proteins are tagged with specific amino acid sequences 




address on a postal package.  Generally, ER targeted membrane proteins that 
lack specific sorting signals are sent to the plasma membrane as a default 
pathway(12). Other membrane proteins contain signals to send them to specific 
compartments in a cell. This sorting decision occurs at the “post office” of the cell, 
the Golgi apparatus.(12)  
 After being synthesized in the ER, membrane proteins are sent through 
the Golgi for packaging and, if lacking a sorting signal, then travel in vesicles out 
to fuse with the plasma membrane (12).  If the protein becomes unfolded or 
unstable at the PM, it is ubiquitinated (signal for degradation added), 
endocytosed, and taken to the early endosome (Fig. 1.1a) (13–16).  The early 
endosome likely serves as a safety compartment in the cell, as it is here that a 
protein can be reevaluated, and a decision made whether to recycle or degrade 
the protein (14, 17).  If the protein appears folded, it can be deubiquitinated 
(signal for degradation removed), and recycled from the early endosome back to 
the PM, to continue functioning there (Fig. 1.1b) (17).  If the protein is unable to 
refold, it continues down the pathway to degradation (Fig. 1.1c).  The early 
endosome matures into a late endosome, while taking its cargo (contents) with it 
(15).  At the late endosome stage, the Endosomal Sorting Complex Required for 
Transport (ESCRT) proteins are recruited (18).  The ESCRTs concentrate cargo 
proteins into a pool on the endosomal membrane (15, 19).  The ESCRTs also 
facilitate the deformation of the membrane, to create an invagination into which 
the deubiquitinated cargo is deposited (Fig. 1.1d).  For cargo to be deposited into 
intralumenal vesicles (ILVs), ubiquitin, the modification that has been added onto 




this stage, in which formation of intralumenal vesicles (ILVs) occurs, the late 
endosome has matured into what is called a multivesicular body (MVB) (19).  The 
MVB then fuses with the lysosome (in higher eukaryotes, vacuole in plants/fungi), 
and releases its ILVs there (Fig. 1.1e) (1, 19).  In the acidic lumen of the 
lysosome/vacuole, ILVs are exposed to lipases and peptidases, which degrade 
both the lipids and the proteins, respectively (1, 19).  From there, the broken up 
amino acids can be recycled and go to the cytoplasm for new protein synthesis.   
 Ubiquitin, as previously mentioned, is considered the universal tag for 
degradation (22).  The 76 amino acid ubiquitin moiety is added to both soluble 
and membrane proteins as a signal to the cell that they need to be degraded (17, 
23).  A single ubiquitin is sufficient as the signal for degradation of membrane 
proteins (24), but polyubiquitin chains are common (15, 25).  Three types of 
enzymes act to add the ubiquitin modification to target proteins: E1, E2, and E3 
enzymes.  E1 enzymes are ubiquitin-activating enzymes, which prepare ubiquitin 
for addition to a target protein.  E2 enzymes are ubiquitin-conjugating enzyme, 
which are responsible for chain assembly and elongation (26). E3 enzymes are 
the ubiquitin ligases – they covalently attach the ubiquitin moiety onto a target 
protein, specifically at a lysine residue (27, 28). 
In the yeast Saccharomyces cerevisiae, there is only one known E3 
ubiquitin ligase that works on proteins at the plasma membrane, called Rsp5 (29–
32).  RSP5 knockout strains are not viable (31), but an rsp5-1 strain contains a 
hypomorphic allele of RSP5 that results in a far less active ubiquitin ligase (33).  
In this strain, proteins are stabilized on the plasma membrane because they are 




within a protein that are targeted for ubiquitination also results in the stabilization 
of the mutant protein on the plasma membrane (35, 36). 
Either monoubiquitin or polyubiquitin chains may be formed on a cargo 
protein.  Polyubiquitin chains can be made through differing linkages as well, 
meaning another ubiquitin can be added onto any one of the 7 lysines within 
ubiquitin (37).  All of these variations may signal different fates for target proteins 
(38).  The standard convention is that K63 polyubiquitin chains are typically 
formed for the degradation of transmembrane proteins through the MVB pathway, 
while K48 linkages are used to direct soluble proteins to the proteasome for 
degradation (15, 39, 40). 
 
1.3 Fur4 as a Model Protein in Yeast 
To study quality control at the plasma membrane, we work with the yeast 
Saccharomyces cerevisiae as our model organism.  S. cerevisiae is a good 
choice as it is hardy, inexpensive, and easy to genetically modify as we keep it in 
the haploid state. Our chosen model protein is Fur4.  Fur4 is the yeast uracil 
transporter.  It is a member of the nucleobase cation symport-1 (NCS-1) family; it 
pumps uracil in along with a proton (symport), using the proton gradient to move 
uracil against its gradient (41, 42).  Fur4, at 633 amino acids, is a large 
transporter, containing 12 transmembrane domains (43).  Because the transport 
of uracil requires large conformational changes in Fur4, this protein is rather 
unstable.  The physical arrangement of these domains and loop regions, and 
their movements during pumping, can be estimated based on knowledge of the 




Based on that structure, Keener & Babst (2013) predicted Fur4 to have an N-
terminal LID region, or Loop Interaction Domain, which as it sounds, interacts 
with the loop regions of the transmembrane domains on the cytosolic side (35).  
Also present on the N-terminus is a degron, a series of phosphorylation and 
ubiquitination sites (lysines); presence of which is sufficient for recognition and 
degradation of a target protein (35, 45, 46) (Fig. 1.2). 
Many studies have found that the yeast uracil permease Fur4 is 
downregulated upon addition of substrate (i.e., uracil) to the culture (16, 35, 47, 
48).  Downregulation efficiency was similar to that seen with heat shock or 
hydrogen peroxide treatment, known triggers of protein unfolding and 
endocytosis (35).  Keener & Babst (2013) proposed that the flexible Fur4 must go 
through large conformational changes to allow the transport of uracil, and during 
this time out of the ground state, the protein may look unfolded (35).  Their idea is 
that the LID region actually acts like a lid on Fur4, keeping closed in the ground 
state (35).  In the ground state, within the N-terminal 110 amino acids are 
residues that make contact with the loops of the transmembrane domains; this 
interaction is what holds the LID “shut” while also contributing to the protein’s 
stability (35).  While the LID is “shut” the degron is tucked in, preventing its 
accessibility (35) (Fig. 1.2a).  But during pumping of substrate, the LID must open 
up to allow binding and release of uracil to the cytosol.  During this time spent 
open, the LID-loop interactions are lost and the degron is exposed, and thus 
accessible to ubiquitination (35) (Fig. 1.2b).  Under this model, simple diffusion 
and chance determine ubiquitination probability.  During degron exposure, if the 




time spent in the non-ground state equals longer degron exposure, and greater 
chance of a run in with Rsp5, which leads to ubiquitination and endocytosis.  This 
is called an intrinsic sensing mechanism in that Fur4 itself senses when it is 
unfolded by loss of LID-loop interactions and degron exposure, and thus presents 
iteslf for ubiquitination (35).  This QC mechanism works independently of 
chaperones, as opposed to CFTR quality control (1, 35). 
Support for the LID-degron idea comes from experimental manipulation of 
Fur4 protein.  Deletion of the N-terminal 60 amino acids, what is deemed the 
degron, resulted in stabilization of Fur4 on the plasma membrane, even under 
conditions that should result in its downregulation (e.g., heat shock, peroxide 
treatment, and high substrate addition) (35).  Alternatively, lysine-to-arginine 
mutation of residues within the degron also results in Fur4 stabilization under 
these conditions (35).  This demonstrates that the degron, and specifically lysine 
ubiquitination sites, are necessary for Fur4 downregulation.  Fur4 in the rsp5-1 
strain is also stabilized at the plasma membrane, in spite of cell stress and 
substrate addition (35).  This shows ubiquitination is necessary for Fur4 
downregulation.  
Since we have a supported model of Fur4 behavior at the plasma 
membrane, it is a good transporter to use in our studies.  Additionally, its flexible 
nature and instability make Fur4 a model protein for our quality control 
experiments: unfolding can easily be induced, causing ubiquitination and 
endocytosis of Fur4.   
Endocytosis of Fur4 can be induced by three modes: 1) cell starvation, 




cell via heat shock, peroxide treatment, etc.; or 3) addition of high uracil 
concentration.  The first mode is understood to occur as part of starvation 
response pathways like TORC1 (Target Of Rapamycin Complex 1), which are 
involved in nutrient sensing and turnover of proteins in response to low nutrients 
(49).  The second mode is more straightforward – the use of known cell stressors 
to cause protein unfolding by disrupting chemical interactions that hold the 
protein in its folded conformation.  The third mode, substrate induced 
downregulation, had been observed previously, but was not well understood until 
the new mechanism was proposed and published by Kenner & Babst in 2013 
(35).  The second and third modes both use the same mechanism resulting in 
endocytosis – the LID-degron system described above – and thus, these are the 

















Fig. 1.1:  General Trafficking Route of a Plasma Membrane Protein 
a. A plasma membrane protein undergoes endocytosis, and is sent to the 
endosome.  b. Endosomal membrane recycles, and can carry cargo protein with 
it, to fuse back with the plasma membrane.  c. Alternatively, a protein continues 
down the path to degradation, traveling from endosome to MVB.  d. ESCRTs are 
recruited to facilitate deposition of cargo proteins into ILVs.  e. MVB fuses with 
vacuole/lysosome, releasing its contents for degradation there. 

















Fig. 1.2: Fur4 Conformational Changes 
Without substrate bound, Fur4 is in the ground state, with LID closed and degron 
tucked away from Rsp5 access.  During substrate pumping, Fur4 undergoes 
large conformational changes that cause the LID to open up, exposing the 
degron.  Fur4 deviates from the ground state any time uracil binds, but can revert 








A NOVEL MODEL:  ENDOSOMAL QUALITY CONTROL  
AND RETENTION SYSTEM 
 
2.1 Introduction 
2.1.1 Early Endosome Dynamics 
After endocytosis of a plasma membrane protein, it travels to the early 
endosome, where a decision is made whether to continue down the path to 
degradation or to recycle back to the plasma membrane.  But how is this QC 
decision made and carried out?  In the case of Fur4, we understand the quality 
control mechanism in place at the plasma membrane, but we do not know much 
about the second QC system in place at the early endosome.  There is plenty of 
evidence of dynamic ubiquitination and deubiquitination of cargo proteins, which 
points to a method of executing this decision (1, 25, 50, 51).  At the early 
endosome, ubiquitin ligase can add ubiquitin moieties to a protein, while ubiquitin 
proteases can cleave off ubiquitin moieties.  Again, the only known ubiquitin 
ligase working at the early endosome is Rsp5 (29–32).  There are many 
deubiquitinating enzymes (or DUBs) in a cell – potentially around 100 in human 
and 17 in yeast – possibly of gene families that evolved to function at different 




deubiquitinating enzymes Ubp2 and Ubp7 as likely to be working at the early 
endosome, based on evidence of their action on Ede1, an endocytic protein, and 
based on their interactions with proteins known to be functioning around this 
stage (25, 54). 
A simplistic idea follows that upon reaching the early endosome, a cargo 
protein either is deubiquitinated and recycled back to the plasma membrane, or it 
is reubiquitinated/polyubiquitinated and goes along with the maturing endosome 
to be degraded in the vacuole.  In this scenario, ubiquitination status is the key 
sorting signal to determine protein fate.  Degradation is the signal mediated path, 
requiring presence of ubiquitin (the signal), while recycling to the plasma 
membrane is the default path taken in absence of ubiquitin.  If this is the case, the 
system could be upset by perturbation of the enzymes Rsp5, Ubp2, or Ubp7.  
Removal of Rsp5 from the system would, we expect, result in cargo proteins 
lacking ubiquitin sorting signals, and recycling by default back to the plasma 
membrane. (This idea of course is convoluted by the fact that Rsp5 works at the 
plasma membrane too, so initial endocytosis would be largely impaired.)  On the 
other hand, removal of the DUBs from the system would result in cargo proteins 
remaining ubiquitinated or growing long polyubiquitin chains, and going forth with 
the maturing endosome to be eventually degraded in the vacuole.  This is what is 
expected if quality control at the early endosome is a straightforward system 
whereby ubiquitin ligase adds ubiquitin to a protein that appears unfolded, and 
DUBs remove ubiquitin from an apparently folded protein.  In the case of Fur4, 
and based on the work done by Keener & Babst (2013), “appearing unfolded” 




degron is neatly tucked away, inaccessible to Rsp5.  So, the decision made at 
the early endosome would be dependent on whether a protein appears unfolded 
or folded and on corresponding ubiquitination status.   
Rechecking of proteins at the early endosome is very important as this 
step allows the balance of cell integrity with energy conservation, and it seems to 
be the stage when the final decision is made on a protein’s fate.  It is also a very 
common process to recycle PM proteins, as in the example of CFTR that was 
given (10, 55).  Proteins may become temporarily unfolded, but they can be 
safely brought inside the cell for reevaluation by the second QC system, and then 
ubiquitin ligases/proteases can modify the protein accordingly to facilitate the 
decision.  However, the quality control scenario presented is a very simplistic 
idea and current research suggests the process is not so black and white. 
 
2.1.2 Key Proteins Involved at the Early Endosome 
To delve into the complexity of the quality control system at the early 
endosome, a deeper look at the proteins at work is warranted.  There is plenty of 
evidence that Rsp5, Ubp2, and Ubp7 do not work independently of each other or 
of other proteins (25, 50, 51, 56).  On the contrary, many of these proteins 
physically interact with each other (25).  Pull down assays (with addition of 
mutation of predicted binding sites) plus immunoblotting were used to develop a 
protein interaction map, as published (25).  That data, in addition to similar 
experiments, informed the interaction map shown in Fig. 2.1.  According to the 
map, Rsp5 and Hua1, a protein of unknown function, physically interact with each 




Sla1, part of the upstream endocytic machinery (57).  Ubp7 interacts with Hse1 
as well (25).  The protein Rup1 stands for Rsp5-Ubp2 interaction Protein; 
essentially, Rup1 tethers the ubiquitin ligase to the DUB (50).  The importance of 
these interactions has not been fully elucidated yet, but it is known that their 
interaction is important for controlling sorting efficiency.  For example, it seems 
Rsp5 requires Rup1 for tethering to Ubp2, in order for Rsp5 to efficiently 
ubiquitinate cargo (50, 51).  It has been proposed that this may be due to an 
autoubiquitination process carried out by Rsp5 (56).  The idea is that through 
autoubiquitination, Rsp5 could actually downregulate itself, adding the signal for 
degradation to itself, and then Ubp2 acts on Rsp5 by removing the ubiquitin it 
adds to itself.  But others argue this is not the reason for Rsp5’s requirement of 
Ubp2 for efficient ubiquitination of cargo, due to the fact that deletion or 
overexpression of Ubp2 does not alter steady state levels of Rsp5 (50). 
The four main proteins we have focused on are Rsp5, Rup1, Ubp2, and 
Hua1.  All are soluble proteins and all are recruited to the endosomal membrane 
(according to a mass of data from the Saccharomyces Genome Database).  We 
think these four proteins function in quality control at the endosome.  We believe 
they work after the upstream endocytic machinery, and before the downstream 
ESCRT machinery takes over.  But how exactly they function together at the 
endosome is unknown. 
 
2.1.3 New Model of QC at the Endosome 
How do the ubiquitin ligase and DUBs work together at the early 




study attempts to address.  The simple model of dynamic ubiquitination and 
deubiquitination does not suffice.  Evidence at odds with this simple model is 
abundant.  The biggest problem is that UBP2 deletion experiments have shown 
increased recycling of cargo, and less degradation (51).  Published growth 
assays have shown hypersensitivity to drugs in ubp2Δ cells, indicating a greater 
presence of the transporter at the plasma membrane, indicative of increased 
recycling (51). Pulse chase experiments confirmed this, with Fur4-GFP remaining 
on the plasma membrane even after addition of uracil substrate (51).  This is in 
stark contrast to what is expected.  Deletion of the deubiquitinating enzyme Ubp2 
should lead to more ubiquitination and thus more degradation of plasma 
membrane proteins, but only the first prediction holds true.  Deletion of UBP2 
does result in increased polyubiquitination, as demonstrated through 
immunoblotting against ubiquitin in ubp2Δ cells (58).  But in looking at Fur4, it did 
not lead to concomitant increased degradation as expected.  There is clearly 
more going on at the early endosome than just ubiquitination versus 
deubiquitination of cargo proteins.  The goal of this study was to attempt to 
reconcile these unexpected results and explore new models of quality control at 
the early endosome. 
Based on current knowledge, we came up with a new model whereby the 
aforementioned proteins – particularly Rsp5, Ubp2, Hua1, and Rup1 – work in a 
complex to retain cargo proteins at the early endosome.  We have dubbed this 
model EQRS = Endosomal Quality control & Retention System.  The idea is that 
while a cargo protein goes through a cycle of ubiquitination and deubiquitination, 




attached ubiquitin moieties.  All of these interactions keep the cargo protein at the 
early endosome.  After a period of cycling, whatever remains will continue with 
the maturing endosome, through the MVB pathway, to eventually be degraded.  
While ubiquitin is still the signal for degradation, and lack thereof should default 
to recycling, under this model, retention is the key sorting step.  So disruption of 
EQRS components could disrupt the whole complex and thus retention, causing 
a loss of regulated sorting at the endosome.  (Fig. 2.2)  The model draws 
comparisons from the system of glycosylation at the ER, whereby keeping a 
soluble protein in a cycle of glycosylation and de-glycosylation reactions retains 
the protein in the ER (2). 
 
2.2 Materials and Methods 
2.2.1 Strains & Growth Conditions 
 Saccharomyces cerevisiae strains used for this study are listed in Table 
2.1.  Strains were created as follows: PCR was done on integration plasmid 
templates containing a selectable marker (e.g., G418 resistance, HIS 
auxotrophy), and fluorescent tag where needed, with primers designed to add 50 
bp flanking regions of homology from target genes; transformation into wildtype 
yeast strain SEY 6210 allowed homologous recombination of the marker/tag into 
the genome; selection markers allowed for picking of colonies with the edited 
genome.  New strains were confirmed by PCR analysis of genomic DNA.  Yeast 
strains were grown at 30°C in common YPD (Yeast extract-Peptone-Dextrose), 
or in YNB (Yeast Nitrogen Base) supplemented with all amino acids except 




promoted Fur4-GFP (pJK19), 50 µM copper sulfate was added to the growth 
media.  Induction of substrate-induced downregulation was done by adding 
2g/100ml uracil to the media.  Heat shock treatment involved swirling culture 
tubes in a 37°C water bath to shock, and then transfer to a 37°C shaking 
incubator for between 15-45 minutes. 
 
2.2.2 DNA Manipulations 
Plasmids used for this work are listed in Table 2.1.  Genes were amplified 
by PCR from genomic SEY6210.  Restriction enzyme cloning was then used to 
insert the gene into a pRS4 series vector, with promoters as specified in Table 
2.1.  Plasmids were amplified in XL1-Blue strain of Escherichia coli, grown in 
standard LB media at 37°C, and selected for with addition of 100g/ml ampicillin to 
the media.  For construction of the ubp2C745A mutant: a plasmid was created 
through PCR mutagenesis and homologous recombination.  PCR amplification of 
two fragments of UBP2 was done on a UBP2 containing plasmid (pKF17), using 
M13R universal primer as forward with a UBP2 reverse primer with base 
substitution, and T7 universal primer as reverse with a UBP2 forward primer with 
base substitution.  Use of M13R and T7 created regions of homology to the MCS 
of a pRS vector.  The two PCR fragments could then be transformed with a 
gapped vector into yeast, and homologous recombination stitched together the 
three fragments, creating the plasmid pKF19.  pKF19 size was confirmed by 






2.2.3 Fluorescence Microscopy 
 A deconvolution microscope (DeltaVision, Applied Precision) was used to 
perform all fluorescent microscopy in the present study.  Cells were typically 
grown to 0.6-0.8 OD600/ml (log phase) before harvesting for microscopy.  The 
different strains were analyzed for Fur4-GFP cellular distribution, observing 
presence/absence and relative amount of protein in compartments along the 
endocytic trafficking route: plasma membrane, endosomes, MVBs, vacuole. 
 
2.2.4 5-Fluorouracil (5-FU) Growth Assays 
 YNB plates were made without uracil (and without specific plasmid 
selection markers when required), and 5-Fluorouracil (5-FU) was added to the 
plates prior to pouring.  2μM 5-FU was determined to be the optimal 
concentration for these growth assays.  Cultures were allowed to grow to ~0.7 
OD600/ml before harvesting for the assay.  Cells were diluted in 1M sorbitol to a 
final concentration of 0.5 OD600/1ml.  A 1:5 dilution series was done in sorbitol in 
a 96-well plate.  3μl of the cells in sorbitol were plated, and images were captured 
after 1-4 days of growth at 30°C. 
 
2.2.5 Western Blotting 
 Cells were grown to log phase and a total of 3 OD600 of cells were 
harvested for protein preps.  After centrifiguation, cells were resuspended in 6M 
urea sample buffer plus 100μl/ml β-mercaptoethanol.  Cells were vortexed with 
glass beads and heated at 65°C for 5 minutes (2x).  8% SDS-PAGE gels were 




rabbit-αSnf7 (loading control), while secondary antibodies were goat-αmouse 
(800 channel) and goat-αrabbit (680 channel).  Blots were imaged on Licor 
Odyssey scanner and analyzed with Image Studios 4.0. 
 
2.3 Results 
2.3.1 Localization of EQRS Components 
 Our first priority was to confirm that the four key proteins in the EQRS 
complex are recruited to the endosome.  Rsp5 has already been localized to 
endosomes, as well as the plasma membrane (32).  To localize the other 
components, we made genomic integrations of GFP tags on RUP1, HUA1, and 
UBP2.  Hua1-GFP had such low and diffuse expression, it was difficult to tell 
whether it specifically localized to the endosome.  Rup1-GFP and Ubp2-GFP 
were also diffuse in the cell, but possibly appeared concentrated in small dots 
near the plasma membrane (likely endosomes).  For further proof, we looked at 
the GFP-tagged proteins in a vps4Δ strain (which accumulates late endosomes), 
and co-localized with mCherry-DID2 (an ESCRT factor tagged with an RFP).  
There was no overlap of the two fluorescent markers, indicating that Rup1 and 
Ubp2 are not in late endosomes, but work upstream of the ESCRTs (Fig. 2.3). 
 
2.3.2 Fur4-GFP Trafficking in Hypomorphic rsp5-1  
 Use of an hypomorphic RSP5 allele results in stabilization of Fur4 on the 
plasma membrane, even under heat shock (Fig. 2.4a).  However, when we look 
at Fur4-GFP in rsp5-1 strain MYY808 by microscopy, there were still some 




Rsp5 activity is severely impaired, but not abolished.  So, Rsp5 can still 
ubiquitinate at the PM, though much less efficiently, and limited endocytosis does 
occur.  However, once at the early endosome, Rsp5 always loses the tug-of-war 
with the DUBs, and thus proteins are deubiquitinated and recycle.  The observed 
phenotype in rsp5-1 strain represents both stabilization of Fur4 on the plasma 
membrane and increased recycling of Fur4 to the PM.   
 
2.3.3 Deletion of EQRS Component Ubp2 
Deletion of UBP2 results in increased polyubiquitination.  Since ubiquitin is 
supposed to be the signal for degradation, it is surprising that deletion of UBP2 
does not lead to increased degradation as expected.  Our retention model is 
based on this anomaly and attempts to explain it.  Therefore, while it has been 
published, we wanted to confirm it with our own experiments.  
We looked by fluorescence microscopy at trafficking of Fur4-GFP in a 
UBP2 deletion strain (ubp2Δ, named MCY66) and observed similar effects (Fig. 
2.5).  Fur4 was stabilized on the plasma membrane, in spite of treatments like 
heat shock or substrate addition, which usually induce downregulation.  In fact, 
the ubp2Δ cells looked more like rsp5-1 cells (Fig. 2.4) than like wildtype cells 
(Fig. 2.5).  Therefore, two strains that are expected to have polar opposite 
phenotypes, if Rsp5 functions solely as a ubiquitin ligase and Ubp2 functions 
solely as a deubiquitinase, actually yield very similar phenotypes.  This indicates 
additional functions for these proteins at the early endosome. 
Additionally, we used growth assays to appraise relative amount of 




on/off switch; if they are at the plasma membrane, they are pumping so long as 
there are substrate and protons to pump.  Therefore, more transporters at the PM 
equals more substrate uptake.  A toxic uracil analog called 5-Fluorouracil (5-FU) 
can be used to indicate uptake of substrate and thus relative amount of 
transporters on the PM.  5-Fluorouracil gets incorporated in RNA and inhibits 
RNA processing, thus inhibiting protein production and cell growth (59).  Cells 
with more Fur4 transporters on the plasma membrane will take up more 5-FU and 
will grow more slowly.  Hence, sensitivity to 5-FU is an indicator of recycling of 
Fur4 to the plasma membrane – more uptake of the drug is indicative of more 
recycling.  The ubp2Δ strain MCY66 is more sensitive to 5-FU than wildtype, 
consistent with increased recycling of Fur4 (Fig. 2.6). 
As a third approach, we used western blotting to look at relative amounts 
of Fur4 degradation, plus or minus treatment.  Looking at the amount of free GFP 
indicates the amount of Fur4-GFP protein that has entered and/or been degraded 
in the vacuole (since GFP is slow to degrade and can persist in the vacuole for 
hours).  Under steady state conditions, more free GFP was present in the 
wildtype strain versus the ubp2Δ strain MCY66 (normalized to Snf7 loading 
control).  This indicates more degradation of Fur4 in wildtype cells than in ubp2Δ 
cells.  After heat shock, there is still more free GFP in wildtype than in ubp2Δ 
cells (Fig. 2.7).  This result is consistent with microscopy and growth assay data, 
and supports the idea that ubp2Δ causes increased recycling of Fur4. 
These results from microscopy, growth assay, and western blotting 
strongly suggest that Ubp2 has other functions in addition to DUB activity, or that 




governance by ubiquitin.  If our EQRS model is accurate, and Ubp2 functions in 
retention of cargo with the aid of the other proteins, the complete deletion of 
Ubp2 likely disrupts the EQRS complex.  This explains why deletion of Ubp2 
increases recycling – because retention is impaired and even ubiquitinated 
proteins escape the early endosome.  Thus, we wanted to look at how an active 
site mutant version of Ubp2 would affect Fur4 trafficking, versus a complete 
deletion of Ubp2 protein.  This would allow us to look at the singular effect of loss 
of DUB activity, without disrupting retention activity.  
 
2.3.4 Complementation with Ubp2 Active Site Mutant  
 We engineered a mutation (C745A) in the active site of Ubp2.  This 
mutation abolishes the deubiquitinase activity of Ubp2, while still allowing it to 
bind ubiquitin and to interact with its normal protein partners (56, 60).  We 
replaced endogenous Ubp2 with ubp2C745A, followed Fur4-GFP trafficking in the 
cell, and used growth assays and western blots to look at how the mutant 
affected degradation of Fur4.  If Ubp2’s role in QC at the early endosome is 
simply deubiquitination, a deletion and a point mutant should influence the 
system in the same way; they should lead to the same outcomes.  However, if 
Ubp2 has a broader role in QC – retention of cargo proteins – then the two 
manipulations will yield very different results.  ubp2Δ causes increased recycling, 
we presume, because of loss of retention of Fur4.  We predicted ubp2C745A would, 
on the contrary, cause increased degradation of Fur4, because retention would 
still be possible while deubiquitination would not. 




complement to ubp2Δ strain (MCY66), Fur4 trafficking as seen by microscopy 
was clearly different from the ubp2Δ without complement added, and wildtype 
(Fig. 2.5).  Fur4 was then degraded more efficiently.  In fact, even under steady 
state conditions with no treatment, Fur4 was already visible in higher amounts 
inside the cell (in endosomes/MVBs/vacuole) than in ubp2Δ alone or wildtype 
(Fig. 2.5).  This phenotype suggests decreased recycling of Fur4. 
 5-Fluorouracil growth assays were consistent with microscopy results.  A 
full deletion of UBP2 grew the worst of strains tested (Fig. 2.6), as would be 
expected with more recycling of Fur4 (more uptake of 5-FU).  On the contrary, 
complementing the ubp2Δ cells with mutant ubp2C745A (pKF19) rescued their 
growth, suggesting increased Fur4 degradation.  Surprisingly, wildtype strain 
SEY6210 and the wildtype UBP2 complement (pKF17) in ubp2Δ strain grew the 
best.  We had predicted the strain with ubp2C745A complement would have grown 
best because of high amounts of Fur4 degradation. 
 Western blot showed overall lower levels of total Fur4 protein in ubp2C745A 
complement versus just ubp2Δ (Fig. 2.7).  Also, with the mutant complement 
there wasn’t much change in relative Fur4 degradation before or after heat shock, 
while in wildtype and ubp2Δ there is a clear increase in degradation following 
heat shock.  Interestingly, the relative amount of Fur4 degradation occurring in 
ubp2C745A complement before heat shock, is about the same amount that occurs 
in ubp2Δ or wildtype after heat shock.  The same trend is evident when looking at 
relative amount of Fur4 protein normalized to Snf7: the amount of Fur4 present in 
ubp2C745A complemented cells before heat shock is about the same amount of 




state there is probably more degradation occurring with the ubp2C745A mutant 
than in ubp2Δ alone or wildtype cells.  This differs slightly from the 5-FU growth 
assay, but is more like what was expected.  As predicted, while ubp2Δ causes 
increased recycling of Fur4, ubp2C745A complement reverses the phenotype 
causing increased degradation of Fur4.  Thus far, results mostly support our 
EQRS model, or at least do not reject it.   
 
2.3.5 Double Knockout of UBP2 and UBP7 
 As stated, there are two DUBs likely working at the early endosome.  
Deletion of UBP7 did not give such a strong phenotype, as compared to deletion 
of UBP2, which is why we focused on Ubp2.  But if both DUBs were 
simultaneously deleted we predicted we might see more degradation, since this 
would theoretically nearly abolish deubiquitination at the early endosome.  And 
microscopy and western blot data weakly suggest this may be correct. 
 Western blot quantification shows slightly increased degradation of Fur4 in 
the double knockout after heat shock, versus wildtype and single ubp2Δ (Fig. 
2.7).  Interestingly, when complemented with ubp2C745A, the double knockout 
strain follows a similar trend as the single ubp2Δ complemented: degradation of 
Fur4 is increased even before heat shock, and there is little change in Fur4 
degradation after heat shock. 
 By microscopy, there is not a clear phenotype of ubp2Δ-ubp7Δ at steady 
state.  Upon treatment though, our ubp2Δ-ubp7Δ strains, KRY5-1 and KRY5-2, 
had more efficient downregulation and degradation than wildtype or ubp7Δ alone.  




mostly endocytosed Fur4 off the plasma membrane, while a lot was remaining at 
the PM in wildtype cells at 30 minutes.  The double knockout strains showed 
most of the GFP signal in vacuoles or endosomes/MVBs, while wildtype had less 
internal signal. 
 
2.3.6 Deletion of EQRS Component Rup1 
Rup1 is known to physically interact with and tether Ubp2 to Rsp5 (50).  
The purpose this serves is not well understood, but it has been shown that Rup1 
modulates activity of Rsp5 and Ubp2 (50, 56).  Could Rup1 be involved in the 
recruitment of both enzymes to the early endosome?  If so, we predict deletion of 
RUP1 would completely dismantle the system. 
We looked by microscopy at Fur4-GFP trafficking in a rup1Δ strain 
(MCY64) (Fig. 2.8).  A phenotype was not very conspicuous, but upon induced 
downregulation by uracil addition, we noticed quicker internalization (or just less 
recycling), and possibly, a delay in Fur4 reaching the vacuole.  60 minutes after 
uracil addition, many of these cells still showed a large amount of GFP signal 
coming from endosomes/MVBs, not as much from the vacuole (where most 
signal is in wildtype after 60 minutes uracil).  It seems Fur4 is still efficiently 
endocytosed in rup1Δ cells, and possibly, undergoes less recycling than wildtype. 
Also, Fur4 becomes stuck in endosomes and doesn’t make it to the vacuole as 
efficiently as usual in rup1Δ cells. 
By growth assay, rup1Δ appears less sensitive to 5-FU than wildtype.  
This data supports the idea of a slight recycling defect when Rup1 is absent.  If 




expected.  However, it may perturb both recycling and degradation, which could 
explain why we see Fur4 stuck in endosomes/MVBs. 
 
2.3.7 Deletion of EQRS Component Hua1 
By microscopy, deletion of HUA1 alone had no real discernible phenotype.  
However, in a 5-FU growth assay hua1Δ did appear to have a growth advantage 
over wildtype.  It is possible that deletion of HUA1 slightly decreases recycling or 
increases degradation, but the effect is so mild it is not detectable by microscopy.   
 
2.3.8 Double Knockout of HUA1 and RUP1 
The lack of obvious phenotypes from deletion of HUA1 or RUP1 may be 
because the EQRS system has some redundancy.  We thought combining HUA1 
and RUP1 deletions in one strain might reveal a clearer phenotype. 
A phenotype did become more evident in RUP1-HUA1 double knockout 
cells after overnight growth.  Typically after overnight growth, when cells have 
entered stationary phase and gone into starvation mode, almost all Fur4 has 
been endocytosed and is in the vacuole being degraded.  This is what was 
observed in wildtype cells and in ubp2Δ-ubp7Δ cells: almost all GFP signal was 
seen in the vacuole.  rup1Δ-hua1Δ cells, however, were loaded with endosomes 
containing Fur4-GFP and even had some signal remaining at the plasma 
membrane after overnight growth to stationary phase.  This supports the idea that 
deletion of RUP1 causes a delay in cargo reaching the vacuole, while 
simultaneous deletion of HUA1 seems to amplify the effect.  The strain has not 





 We confirmed that deletion of UBP2 yields increased recycling, but that 
complementation with a Ubp2 active site mutant increases degradation.  Thus, a 
simple concept of tug-of-war between Rsp5 ubiquitinating and Ubp2 
deubiquitinating cargo proteins at the early endosome is insufficient to account 
for the decision to degrade or recycle, respectively.  Additionally, there are other 
endosome localized proteins that interact with Rsp5 and Ubp2 that cannot be 
ignored, for their interaction must serve a purpose. All four proteins – Rup1, Hua1, 
Rsp5, and Ubp2 – are ubiquitin binding proteins, which suggests a mode for 
engagement with cargo.  We also know Rup1 has a modulatory effect on Rsp5 
and Ubp2, based on previously published data (50, 56).  It has been suggested 
that deletion of Ubp2 results in increased recycling of cargo because of 
autoubiquitination of Rsp5 without competing deubiquitination, thus resulting in 
decreased ubiquitin ligase activity (56).  But our Ubp2 active site mutant data 
rejects that idea, as the mutant should also cause increased Fur4 recycling, if 
loss of DUB activity and thus lower amounts of Rsp5 were the explanation. 
Our EQRS model is bolstered by the UBP2 data.  Complete deletion of 
UBP2 would disrupt the EQRS complex and even ubiquitinated cargo could 
escape retention.  This accounts for the increased recycling observed in cells 
with ubp2Δ.  However, with an active site mutant version of Ubp2, where DUB 
activity is diminished, the EQRS complex can still form and retain cargo. This 
accounts for increased degradation seen in ubp2Δ cells complemented with 
ubp2C745A. 




to ESCRT-0, as it is known to physically interact with Hse1 (25).  Rup1 could also 
have a hand in maturation of endosomes.  These are just ideas that require 
further testing, but it could explain why rup1Δ and rup1Δ-hua1Δ cells have cargo 
stuck in endosomes with delayed progression to vacuoles.  When the cells 
should thoroughly downregulate (i.e., during starvation), Fur4 may be 
endocytosed normally, but become stuck at endosomes during the ubiquitination-
deubiquitination cycle, yet with some escaping back to the plasma membrane 
(but almost immediately being endocytosed again).  
It appears Ubp7 does not play a crucial role at the endosomes as does 
Ubp2.  UBP7 deletion alone does not have a strong phenotype.  However, 
combination with UBP2 deletion does appear to increase degradation, so it may 
be that deletion of the endosomal DUBs drastically reduces deubiquitination and 
ability to recycle.   
The microscopy and growth assay data seems reliable since these 
experiments have been repeated and given the same results.  However, it must 
be noted that the western blot data comes mostly from one blot.  A repeat blot 
showed some of the same trends (but weak) or else no significant trends.  So, 
more blots really need to be performed to get significant data.  Also, in our 
sample preparation procedure, unfortunately, there tends to be degradation 
occurring during the prep.  We have since found a new protocol that should 
quickly stop all activity in the cell to prevent degradation occurring during the 
preps.  Western blots need to be repeated with this new sample prep procedure, 








Table 2.1: Strains and Plasmids Used in This Study 
Strains Description Genotype Source 
SEY 6210 WT 
MATα leu2-3,112 ura3-52 
   his3-Δ200 trp1-Δ901 
   lys2-801 suc2-Δ9 
(61) 
MYY808 rsp5-1 
MYY808 MATα, MDM1, 
   smm1, his3, leu2, ura3 
(62) 
MCY64 rup1Δ SEY 6210, rup1::KanMX This study 
MCY65 ubp7Δ SEY 6210, ubp7::KanMX This study 
MCY66 ubp2Δ SEY 6210, ubp2::KanMX This study 
KRY1 Rup1-GFP SEY 6210, Rup1-GFP::KanMX This study 
KRY2 Ubp2-GFP SEY 6210, Ubp2-GFP::KanMX This study 
KRY4 hua1Δ SEY 6210, hua1::KanMX This study 
KRY5-1 ubp2Δubp7Δ 
SEY 6210, ubp2::TRP1, 
   ubp7::KanMX 
This study 
KRY8 hua1Δrup1Δ 
SEY 6210, hua1::TRP1, 
   rup1::KanMX 
This study 




URA3 (pRS416)  







































Fig. 2.1: Protein Interaction Map 












Fig. 2.2: EQRS (Endosomal Quality control & Retention System) Model 
In this model, the green EQRS box represents a complex of the four key proteins 
– Ubp2, Rsp5, Rup1, and Hua1.  A protein (e.g., Fur4) cycles through dynamic 
deubiquitination and (poly)ubiquitination.  Whatever remains ubiquitinated can be 
caught by the retention complex and held back in the endosome.  Without 
ubiquitin moieties attached, EQRS is not able to retain Fur4 and it escapes, 
recycling to the PM.  Anything held back by EQRS goes along with the maturing 
endosome to be degraded in the vacuole/lysosome.  The EQRS machinery likely 
is reused by falling off around the late endosome stage as the cargo is handed 

















Fig. 2.3: Localization of EQRS Proteins 
The plasma membrane of the cell has been outlined in white dashed line.  These 
cells express a plasmid containing a vps4 dominant negative mutant which 
causes accumulation of late endosomes.  Rup1 or Ubp2 (as indicated) is present 
where GFP is seen.  The ESCRT factor Did2 is present where red mCherry is 
visible, and is used as a marker of late endosomes.  The images show no overlap 
of GFP and mCherry, revealing that EQRS components accumulate on 
compartments that are distinct from late endosomes/MVBs.  This suggests EQRS 
functions upstream of the ESCRTs.  Additionally, without the vps4 mutation, 
Rup1 and Ubp2 are more diffuse in the cell, and harder to specifically localize.  
The fact that they accumulated on late endosomes here suggests that ESCRT 











Fig. 2.4: Microscopy on rsp5-1 Cells 
a. Wildtype shows very efficient downregulation of Fur4 after 60 minutes heat 
shock at 37°C, while Fur4 is stabilized on the PM in rsp5-1 strain before and after 
heat shock. 
b. Pictured is Fur4-GFP in rsp5-1 after 60 minutes +uracil.  The signal in dots 
close to the plasma membrane indicates endosomal compartments.  Efficiency of 









Fig. 2.5: Microscopy on ubp2Δ Cells 
White dashed lines mark the PM.  WT shows normal downregulation after uracil 
addition.  Most GFP signal is in the vacuole, with a little in MVBs.  ubp2Δ shows 
much less GFP in vacuoles than WT, and much more still remaining at the PM, 
indicative of increased recycling of Fur4.  But when complemented with Ubp2 
active site mutant, there is a switch to increased degradation.  It looks very 
similar to WT after uracil, with no signal remaining at the PM.  Before uracil, the 
complement shows much more internal signal, so there is increased degradation 
even at steady state. 
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Fig. 2.6: 5-FU Growth Assay with ubp2Δ Cells 
The UBP2 complement and WT grew best, which indicates less Fur4 on the PM 
(more degradation).  upb2Δ was most sensitive to 5-FU, indicating more Fur4 on 














Fig. 2.7: Western Blot Data 
a. Blot Image: Lanes match in order with the quantification graphs on the 
following page.  The overall trend visible here is a decrease in Fur4 protein after 
heat shock (every 2nd lane) and lower Fur4 protein amounts overall in the double 
ubp2Δ-ubp7Δ (lanes 7-10). 
























































































Fig. 2.8: Microscopy on rup1Δ Cells 
After 30 minutes +uracil, all GFP signal appears in endosomes/MVB, instead of 














3.1 Concluding Remarks and Future Directions 
Maintaining functional proteins at the plasma membrane is vital for nutrient 
uptake, ion exchange for maintenance of membrane potential, and for cell-to-cell 
communication.  Proteins can become unfolded or unstable on the plasma 
membrane, so a quality control system must be in place to take care of these 
proteins. Transporters like Fur4 may become unstable just as a byproduct of their 
natural pumping mechanism.  Hence, Fur4 requires monitoring and removal from 
the plasma membrane to preserve cell integrity.  At the same time, cells need to 
balance integrity with energy conservation, so there is a second QC system in 
place at the endosome to determine whether a PM protein really needs to be 
degraded or if the protein is still able to function and should be conserved.  If a 
protein appears unfolded, it is quickly endocytosed to prevent it from being 
detrimental to the cell, possibly causing loss of membrane potential among other 
problems.  After endocytosis, the protein can either continue down the MVB 
pathway to be degraded in the lysosome/vacuole, or it can be recycled back to 
the plasma membrane.  The choice between these two fates is made at the early 




accepted idea in the field is that ubiquitination status determines a protein’s fate, 
and that the processes of ubiquitination and deubiquitination occurring at the 
early endosome control that fate.  However, numerous experiments on ubp2Δ 
strains suggest a more complex system of quality control at the early endosome.  
It’s clear that deletion of UBP2 causes increased recycling of proteins to the 
plasma membrane, the polar opposite phenotype expected.  So how can this be 
explained? 
That is how the EQRS model was born, to explain these unexpected 
results.  There are many open questions and theories that should be explored 
through further research of this topic.  A future goal is to understand how the 
retention complex is organized and its timing.  What are the functional roles of all 
the key players in our EQRS model?  We still do not know what Hua1 does. 
Which components are essential?  Ubp7 likely is not essential since its deletion 
did not have an obvious phenotype, and there is probably some redundancy with 
Ubp2.  How are the EQRS factors recruited to the endosome?  At what point 
does EQRS hand off cargo to the ESCRTs?  We believe EQRS functions 
upstream of the ESCRTs, so there is likely a step where EQRS leaves prior to or 
in conjunction with ESCRT recruitment.  Answering these questions will help us 
understand the vital second quality control system at work at the early endosome. 
In spite of leaving us with many questions, the present work has added 
support to our EQRS model for the most part, leaving us with many future 















1.  M. Babst, Quality control: quality control at the plasma membrane: one 
mechanism does not fit all. J. Cell Biol. 205, 11–20 (2014). 
2.  J. L. Brodsky, Cleaning up: ER-associated degradation to the rescue. Cell. 
151, 1163–7 (2012). 
3.  R. Hampton, ER-associated degradation in protein quality control and 
cellular regulation. Curr. Opin. Cell Biol., 476–482 (2002). 
4.  M. S. Hipp, S. H. Park, F. U. Hartl, Proteostasis impairment in protein-
misfolding and -aggregation diseases. Trends Cell Biol. 24, 506–514 
(2014). 
5.  K. Cuanalo-Contreras, A. Mukherjee, C. Soto, Role of protein misfolding 
and proteostasis deficiency in protein misfolding diseases and aging. Int. J. 
Cell Biol. 2013, 1–10 (2013). 
6.  W. Scheper, D. a T. Nijholt, J. J. M. Hoozemans, The unfolded protein 
response and proteostasis in Alzheimer disease: Preferential activation of 
autophagy by endoplasmic reticulum stress. Autophagy. 7, 910–911 (2011). 
7.  G. L. Lukacs, a. S. Verkman, CFTR: Folding, misfolding and correcting the 
DF508 conformational defect. Trends Mol. Med. 18, 81–91 (2012). 
8.  C. L. Ward, R. R. Kopito, Intracellular turnover of cystic fibrosis 
transmembrane conductance regulator. Inefficient processing and rapid 
degradation of wild-type and mutant proteins. J. Biol. Chem. 269, 25710–
25718 (1994). 
9.  G. L. Lukacs et al., The DF508 mutation decreases the stability of cystic 
fibrosis transmembrane conductance regulator in the plasma membrane. J 
Biol Chem. 268, 21592–21598 (1993). 
10.  A. Swiatecka-Urban et al., The short apical membrane half-life of rescued  
ΔF508-cystic fibrosis transmembrane conductance regulator (CFTR) 
results from accelerated endocytosis of  ΔF508H-CFTR in polarized human 




11.  B. Alberts et al., in Molecular Biology of the Cell, M. Anderson, S. Granum, 
Eds. (Garland Science, New York, NY, ed. 5th, 2007), pp. 695–748. 
12.  B. Alberts et al., in Molecular Biology of the Cell, M. Anderson, S. Granum, 
Eds. (Garland Science, New York, NY, ed. 5th, 2007), pp. 749–812. 
13.  L. Hicke, H. Riezman, Ubiquitination of a yeast plasma membrane receptor 
signals its ligand-stimulated endocytosis. Cell. 84, 277–287 (1996). 
14.  M. Jovic, M. Sharma, J. Rahajeng, S. Caplan, The early endosome: A busy 
sorting station for proteins at the crossroads. Histol. Histopathol. 25, 99–112 
(2010). 
15.  E. Lauwers, Z. Erpapazoglou, R. Haguenauer-Tsapis, B. André, The 
ubiquitin code of yeast permease trafficking. Trends Cell Biol. 20, 196–204 
(2010). 
16.  J. M. Galan, V. Moreau, B. Andre, C. Volland, R. Haguenauer-Tsapis, 
Ubiquitination mediated by the Npi1p/Rsp5p ubiquitin-protein ligase is 
required for endocytosis of the yeast uracil permease. J. Biol. Chem. 271, 
10946–10952 (1996). 
17.  M. J. Clague, H. Liu, S. Urbé, Governance of endocytic trafficking and 
signaling by reversible ubiquitylation. Dev. Cell. 23, 457–67 (2012). 
18.  J. H. Hurley, The ESCRT complexes. Crit. Rev. Biochem. Mol. Biol. 45, 
463–487 (2010). 
19.  R. C. Piper, D. J. Katzmann, Biogenesis and function of multivesicular 
bodies. Annu. Rev. Cell Dev. Biol. 23, 519–547 (2007). 
20.  a Y. Amerik, J. Nowak, S. Swaminathan, M. Hochstrasser, The Doa4 
deubiquitinating enzyme is functionally linked to the vacuolar protein-
sorting and endocytic pathways. Mol. Biol. Cell. 11, 3365–3380 (2000). 
21.  N. Luhtala, G. Odorizzi, Bro1 coordinates deubiquitination in the 
multivesicular body pathway by recruiting Doa4 to endosomes. J. Cell Biol. 
166, 717–729 (2004). 
22.  A. Ciechanover, Proteolysis: from the lysosome to ubiquitin and the 
proteasome. Nat. Rev. Mol. Cell Biol. 6, 79–87 (2005). 
23.  L. Hicke, R. Dunn, Regulation of membrane protein transport by ubiquitin 
and ubiquitin-binding proteins. Annu. Rev. Cell Dev. Biol. 19, 141–172 
(2003). 




the internalization of a G protein-coupled receptor. Mol. Cell. 1, 193–202 
(1998). 
25.  J. Ren, Y. Kee, J. M. Huibregtse, R. C. Piper, Hse1, a Component of the 
Yeast Hrs-STAM Ubiquitin-sorting Complex, Associates with Ubiquitin 
Peptidases and a Ligase to Control Sorting Efficiency into Multivesicular 
Bodies. Mol. Biol. Cell. 18, 324–335 (2007). 
26.  Y. Ye, M. Rape, Building ubiquitin chains: E2 enzymes at work. Nat. Rev. 
Mol. Cell Biol. 10, 755–764 (2009). 
27.  S. Urbé, Ubiquitin and endocytic protein sorting. Essays Biochem. 41, 81–
98 (2005). 
28.  S. Jentsch, The ubiquitin-conjugation system. Annu. Rev. Genet., 179–207 
(1992). 
29.  N. Belgareh-Touzé et al., Versatile role of the yeast ubiquitin ligase Rsp5p 
in intracellular trafficking. Biochem. Soc. Trans. 36, 791–796 (2008). 
30.  J. Horák, The role of ubiquitin in down-regulation and intracellular sorting of 
membrane proteins: Insights from yeast. Biochim. Biophys. Acta - 
Biomembr. 1614, 139–155 (2003). 
31.  C. Hein, J.-Y. Springael, C. Volland, R. Haguenauer-Tsapis, B. André, 
NPI1, an essential yeast gene involved in induced degradation of Gap1 and 
Fur4 permeases, encodes the Rsp5 ubiquitin—protein ligase. Mol. 
Microbiol. 18, 77–87 (1995). 
32.  G. Wang et al., Localization of the Rsp5p Ubiquitin-Protein Ligase at 
Multiple Sites within the Endocytic Pathway. Mol. Cell. Biol. 21, 3564–3575 
(2001). 
33.  G. Wang, J. Yang, J. M. Huibregtse, Functional domains of the Rsp5 
ubiquitin-protein ligase. Mol. Cell. Biol. 19, 342–352 (1999). 
34.  J. Liu, A. Sitaram, C. G. Burd, Regulation of copper-dependent endocytosis 
and vacuolar degradation of the yeast copper transporter, Ctr1p, by the 
Rsp5 ubiquitin ligase. Traffic. 8, 1375–1384 (2007). 
35.  J. M. Keener, M. Babst, Quality Control and Substrate-Dependent 
Downregulation of the Nutrient Transporter Fur4. Traffic. 14, 412–427 
(2013). 
36.  C. Marchal, R. Haguenauer-Tsapis, D. Urban-Grimal, Casein kinase 1-
dependent phosphorylation within a PEST sequence and ubiquitination 




275, 23608–23614 (2000). 
37.  W. Dubiel, C. Gordon, Ubiquitin pathway: Another link in the polyubiquitin 
chain? Curr. Biol. 9, 554–557 (1999). 
38.  C. M. Pickart, D. Fushman, Polyubiquitin chains: Polymeric protein signals. 
Curr. Opin. Chem. Biol. 8, 610–616 (2004). 
39.  Z. Erpapazoglou et al., A dual role for K63-linked ubiquitin chains in 
multivesicular body biogenesis and cargo sorting. Mol. Biol. Cell. 23, 2170–
2183 (2012). 
40.  P. Xu et al., Quantitative Proteomics Reveals the Function of 
Unconventional Ubiquitin Chains in Proteasomal Degradation. Cell. 137, 
133–145 (2009). 
41.  P. Hopkins, N. R. Chevallier, R. Jund, A. A. Eddy, Use of plasmid vectors to 
show that the uracil and cytosine permeases of the yeast Saccharomyces 
cerevisiae are electrogenic proton symports. FEMS Microbiol. Lett. 49, 173–
177 (1988). 
42.  S. Weyand et al., Structure and molecular mechanism of a nucleobase-
cation-symport-1 family transporter. Science. 322, 709–713 (2008). 
43.  R. Jund, E. Weber, M.-R. C. Chevallier, Primary structure of the uracil 
transport protein of Saccharomyces cerevisiae. Eur. J. Biochem. 171, 417–
24 (1988). 
44.  T. Shimamura et al., Molecular basis of alternating access membrance 
transport by the sodium hydantoin transporter Mhp1. Science. 328, 470–
473 (2010). 
45.  T. Ravid, M. Hochstrasser, Diversity of degradation signals in the  ubiquitin-
proteasome system. Nat. Rev. Mol. Cell Biol. 9, 679–690 (2008). 
46.  C. Marchal, R. Haguenauer-Tsapis, D. Urban-Grimal, A PEST-like 
sequence mediates phosphorylation and efficient ubiquitination of yeast 
uracil permease. Mol. Cell. Biol. 18, 314–321 (1998). 
47.  M. O. Blondel et al., Direct Sorting of the Yeast Uracil Permease to the 
Endosomal System Is Controlled by Uracil Binding and Rsp5p-dependent 
Ubiquitylation. Mol. Biol. Cell. 15, 883–895 (2004). 
48.  K. Séron, M. O. Blondel, R. Haguenauer-Tsapis, C. Volland, Uracil-induced 





49.  C. B. Jones et al., Regulation of Membrane Protein Degradation by 
Starvation-Response Pathways. Traffic. 13, 468–482 (2012). 
50.  Y. Kee, N. Lyon, J. M. Huibregtse, The Rsp5 ubiquitin ligase is coupled to 
and antagonized by the Ubp2 deubiquitinating enzyme. EMBO J. 24, 2414–
2424 (2005). 
51.  M. H. Y. Lam et al., Interaction of the deubiquitinating enzyme Ubp2 and 
the E3 ligase Rsp5 is required for transporter/receptor sorting in the 
multivesicular body pathway. PLoS One. 4 (2009), 
doi:10.1371/journal.pone.0004259. 
52.  S. Urbe et al., Systematic survey of deubiquitinase localization identifies 
USP21 as a regulator of centrosome- and microtubule-associated 
functions. Mol. Biol. Cell. 23, 1095–1103 (2012). 
53.  A. Y. Amerik, S.-J. Li, M. Hochstrasser, Analysis of the Deubiquitinating 
Enzymes of the Yeast Saccharomyces cerevisiae. Biol. Chem. 381, 981–
992 (2005). 
54.  J. S. Weinberg, D. G. Drubin, Regulation of Clathrin-Mediated Endocytosis 
by Dynamic Ubiquitination and Deubiquitination. Curr. Biol. 24, 951–959 
(2014). 
55.  F. R. Maxfield, T. E. McGraw, Endocytic recycling. Nat. Rev. Mol. Cell Biol. 
5, 121–132 (2004). 
56.  M. H. Y. Lam, A. Emili, Ubp2 Regulates Rsp5 Ubiquitination Activity In Vivo 
and In Vitro. PLoS One. 8 (2013), doi:10.1371/journal.pone.0075372. 
57.  S. D. Stamenova, R. Dunn, A. S. Adler, L. Hicke, The Rsp5 Ubiquitin 
Ligase Binds to and Ubiquitinates Members of the Yeast CIN85-Endophilin 
Complex, Sla1-Rvs167. J. Biol. Chem. 279, 16017–16025 (2004). 
58.  Y. Kee, W. Muñoz, N. Lyon, J. M. Huibregtse, The deubiquitinating enzyme 
Ubp2 modulates Rsp5-dependent Lys 63-linked polyubiquitin conjugates in 
Saccharomyces cerevisiae. J. Biol. Chem. 281, 36724–36731 (2006). 
59.  S. S. Cohen, J. G. Flaks, H. D. Barner, M. R. Loeb, J. Lichtenstein, The 
Mode of Action of 5-Fluorouracil and Its Derivatives. Proc. Natl. Acad. Sci. 
U. S. A. 44, 1004–1012 (1958). 
60.  R. T. Baker, J. W. Tobias, A. Varshavsky, Ubiquitin-specific proteases of 
Saccharomyces cerevisiae: Cloning of UBP2 and UBP3, and functional 
analysis of the UBP gene family. J. Biol. Chem. 267, 23364–23375 (1992). 




Saccharomyces cerevisiae: isolation of mutants defective in the delivery 
and processing of multiple vacuolar hydrolases. Mol. Cell. Biol. 8, 4936–
4948 (1988). 
62.  H. a. Fisk, M. P. Yaffe, A role for ubiquitination in mitochondrial inheritance 
in Saccharomyces cerevisiae. J. Cell Biol. 145, 1199–1208 (1999). 
63.  S. Kametaka et al., Canonical interaction of cyclin G associated kinase with 
adaptor protein 1 regulates lysosomal enzyme sorting. Mol. Biol. Cell. 18, 
2991–3001 (2007). 
64.  B. A. Davies et al., Coordination of substrate binding and ATP hydrolysis in 
Vps4-mediated ESCRT-III disassembly. Mol. Biol. Cell. 21, 3396–3408 
(2010).  
 
 
 
